Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul-Sep;13(3):107-115.
doi: 10.18502/ajmb.v13i3.6370.

The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds

Samira Mahmoudi  1 , Negar Balmeh  2 , Niloofar Mohammadi  3 , Tahereh Sadeghian-Rizi  4
Affiliations

The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds

Samira Mahmoudi et al. Avicenna J Med Biotechnol. 2021 Jul-Sep.

Abstract

Background: The cause of COVID-19 global pandemic is SARS-CoV-2. Given the outbreak of this disease, it is so important to find a treatment. One strategy to cope with COVID-19 is to use the active ingredients of medicinal plants. In this study, the effect of active substances was surveyed in inhibiting four important druggable targets, including S protein, 3CLpro, RdRp, and N protein. RdRp controls the replication of SARS-CoV-2 and is crucial for its life cycle. 3CLpro is the main protease of the virus and could be another therapeutic target. Moreover, N protein and S protein are responsible for SARS-CoV-2 assembly and attaching, respectively.

Methods: The 3D structures of herbal active ingredients were prepared and docked with the mentioned SARS-CoV-2 proteins to obtain their affinity. Then, available antiviral drugs introduced in other investigations were docked using similar tools and compared with the results of this study. Finally, other properties of natural compounds were uncovered for drug designing.

Results: The outcomes of the study revealed that Linarin, Amentoflavone, (-)-Catechin Gallate and Hypericin from Chrysanthemum morifolium, Hypericum perforatum, Humulus lupulus, and Hibiscus sabdariffa had the highest affinity for these basic proteins and in some cases, their affinity was much higher than antiviral medicines.

Conclusion: In addition to having high affinity, these herb active ingredients have antioxidant, vasoprotective, anticarcinogenic, and antiviral properties. Therefore, they can be used as extremely safe therapeutic compounds in drug design studies to control COVID-19.

Keywords: COVID-19; Drug design; Medicinal plants; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Affinity of top scoring medicinal herbal compounds to inhibit the S protein, 3CLpro, RdRp, and N protein. A) the interaction between Amentoflavone from Hypericum perforatum (Purple) and S protein (Orange red); B) the interaction between Linarin from Chrysanthemum morifolium (Deep pink) and N protein (Light sea green); C) the interaction between Amentoflavone from Hypericum perforatum (Orang) and 3CLpro (Olive drab); D) the interaction between Amentoflavone from Hypericum perforatum (Violet red) and RdRp (Sandy brown).
See this image and copyright information in PMC

References

    1. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579 (7798):270–3. - PMC - PubMed
    1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265–9. - PMC - PubMed
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. Gorbalenya AA, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 2020:536–44. - PMC - PubMed
    1. Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol 2020;42(1):3–11. - PubMed
    1. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814–20. - PubMed

LinkOut - more resources